1. Assess sarcopenia prevalence in elderly diabetic patients. 2. Evaluate impact of diabetes and its medications on muscle health. 3. detect effect of sacropenia on quality of life on elderly
Study Type
OBSERVATIONAL
Enrollment
100
Bedside muscle ultrasound to measure muscle thickness, cross-sectional area and echogenicity
Prevalence of sarcopenia assessed by muscle ultrasound in elderly diabetic
Sarcopenia will be evaluated using muscle ultrasound to measure muscle thickness and echo intensity of the quadriceps muscle. The results will be interpreted according to EWGSOP2 diagnostic criteria, which combine muscle mass and muscle strength parameters
Time frame: Within 6 months from the start of recruitment.
Assessment of muscle strength using handgrip dynamometry
Handgrip strength will be measured using a handheld dynamometer, and the average of three attempts for the dominant hand will be recorded.
Time frame: Within 6 months
Quality of life score using the SarQoL questionnaire.
Quality of life related to sarcopenia will be evaluated using the validated SarQoL questionnaire.
Time frame: Within 6 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.